The use of a genetic algorithm neural network (GANN) for prognosis in surgically treated nonsmall cell lung cancer (NSCLC)

M. F. Jefferson, N. Pendleton, S. B. Lucas, M. A. Horan

Research output: Chapter in Book/Conference proceedingChapterpeer-review

Abstract

I. INTRODUCTION No ns mall Cell Lung Cancer (NSCLC) accounts for approximately three quarters of all lung cancer his to logies. Surgical resection is the preferred treatment and approximately 50,000 operations are performed in the United States alone each year [1]. The over all prognosis for resected NSCLC is poor with fewer than a third of patients who undergo resection still alive 5 year s later [2].

Original languageEnglish
Title of host publicationArtificial Neural Networks in Cancer Diagnosis, Prognosis, and Patient Management
EditorsRaouf N.G. Naguib, Gajanan V. Sherbet
PublisherCRC Press
Pages39-54
Number of pages16
ISBN (Electronic)9781420036381
ISBN (Print)0849396921, 9780849396922
Publication statusPublished - 1 Jan 2001

Fingerprint

Dive into the research topics of 'The use of a genetic algorithm neural network (GANN) for prognosis in surgically treated nonsmall cell lung cancer (NSCLC)'. Together they form a unique fingerprint.

Cite this